NASDAQ:TCRR - Tcr2 Therapeutics Earnings Date, Estimates & History

+1.63 (+11.16 %)
(As of 06/18/2019 04:00 PM ET)
Today's Range
Now: $16.24
50-Day Range
MA: $15.25
52-Week Range
Now: $16.24
Volume15,655 shs
Average Volume40,168 shs
Market Capitalization$388.79 million
P/E RatioN/A
Dividend YieldN/A


Tcr2 Therapeutics (NASDAQ:TCRR) Earnings History and Estimates Chart

Earnings by Quarter for Tcr2 Therapeutics (NASDAQ:TCRR)

Tcr2 Therapeutics (NASDAQ:TCRR) Earnings Estimates

2019 EPS Consensus Estimate: ($2.20)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20193($0.45)($0.34)($0.38)
Q2 20193($0.51)($0.49)($0.50)
Q3 20193($0.66)($0.55)($0.60)
Q4 20193($0.85)($0.60)($0.72)

Tcr2 Therapeutics (NASDAQ TCRR) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/13/20193/31/2019($0.38)($4.85)($4.85)ViewListenView Earnings Details
4/1/2019Q4 2018($0.38)($16.22)($16.22)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)
This page was last updated on 6/18/2019 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.

Yahoo Gemini Pixel